Boston Scientific Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US1011371077
USD
69.48
-1.72 (-2.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
5,286.00
5,065.00
5,061.00
4,663.00
4,561.00
4,209.00
4,120.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,286.00
5,065.00
5,061.00
4,663.00
4,561.00
4,209.00
4,120.00
Raw Material Cost
1,665.00
1,757.00
1,883.00
1,713.00
1,890.00
1,561.00
1,535.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.00
96.00
99.00
87.00
139.00
83.00
81.00
Selling and Distribution Expenses
1,834.00
1,741.00
1,716.00
1,597.00
1,612.00
1,562.00
1,446.00
Other Expenses
53.50
41.80
42.70
35.60
32.10
32.40
30.20
Total Expenditure (Excl Depreciation)
4,068.00
4,012.00
4,125.00
3,753.00
3,962.00
3,530.00
3,364.00
Operating Profit (PBDIT) excl Other Income
1218
1053
936
910
599
679
756
Other Income
-271.00
5.00
375.00
53.00
-99.00
110.00
3.00
Operating Profit (PBDIT)
1,306.00
1,388.00
1,633.00
1,274.00
838.00
1,091.00
1,061.00
Interest
34.00
96.00
99.00
87.00
139.00
83.00
81.00
Exceptional Items
-206.00
-13.00
-256.00
-57.00
233.00
-33.00
-249.00
Gross Profit (PBDT)
3,621.00
3,308.00
3,178.00
2,950.00
2,671.00
2,648.00
2,585.00
Depreciation
365.00
342.00
336.00
325.00
348.00
307.00
311.00
Profit Before Tax
700.00
938.00
941.00
805.00
585.00
668.00
420.00
Tax
30.00
183.00
146.00
133.00
23.00
200.00
98.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
672.00
755.00
797.00
674.00
566.00
469.00
324.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
672.00
755.00
797.00
674.00
566.00
469.00
324.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.00
0.00
-2.00
-2.00
-4.00
-1.00
-2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
670.00
755.00
795.00
672.00
562.00
468.00
322.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
24,233.00
23,394.00
22,418.00
22,212.00
21,770.00
20,708.00
20,371.00
Earnings per share (EPS)
0.45
0.5
0.53
0.45
0.38
0.32
0.22
Diluted Earnings per share
0.45
0.5
0.53
0.45
0.38
0.32
0.22
Operating Profit Margin (Excl OI)
22.93%
20.55%
18.22%
19.22%
12.91%
16.01%
18.13%
Gross Profit Margin
20.15%
25.27%
25.23%
24.23%
20.46%
23.16%
17.74%
PAT Margin
12.71%
14.91%
15.75%
14.45%
12.41%
11.14%
7.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.36% vs 0.08% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -11.26% vs -5.03% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 14.03% vs 9.94% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -64.58% vs -3.03% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Boston Scientific Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
5,286.00
1,06,158.00
-1,00,872.00
-95.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,286.00
1,06,158.00
-1,00,872.00
-95.02%
Raw Material Cost
1,665.00
1,02,676.00
-1,01,011.00
-98.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
34.00
63.00
-29.00
-46.03%
Selling and Distribution Expenses
1,834.00
1,842.00
-8.00
-0.43%
Other Expenses
53.50
-6.30
59.80
949.21%
Total Expenditure (Excl Depreciation)
4,068.00
1,04,518.00
-1,00,450.00
-96.11%
Operating Profit (PBDIT) excl Other Income
1,218.00
1,640.00
-422.00
-25.73%
Other Income
-271.00
74.00
-345.00
-466.22%
Operating Profit (PBDIT)
1,306.00
1,902.00
-596.00
-31.34%
Interest
34.00
63.00
-29.00
-46.03%
Exceptional Items
-206.00
-21.00
-185.00
-880.95%
Gross Profit (PBDT)
3,621.00
3,482.00
139.00
3.99%
Depreciation
365.00
188.00
177.00
94.15%
Profit Before Tax
700.00
1,630.00
-930.00
-57.06%
Tax
30.00
380.00
-350.00
-92.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
672.00
1,186.00
-514.00
-43.34%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
672.00
1,186.00
-514.00
-43.34%
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.00
64.00
-66.00
-103.12%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
670.00
1,250.00
-580.00
-46.40%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
24,233.00
-1,298.00
25,531.00
1,966.95%
Earnings per share (EPS)
0.45
9.59
-9.14
-95.31%
Diluted Earnings per share
0.45
9.59
-9.14
-95.31%
Operating Profit Margin (Excl OI)
22.93%
1.54%
0.00
21.39%
Gross Profit Margin
20.15%
1.71%
0.00
18.44%
PAT Margin
12.71%
1.12%
0.00
11.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 528.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 4.36% vs 0.08% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 15.90% vs 22.44% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 67.00 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -11.26% vs -5.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.22% vs 11.51% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 157.70 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.03% vs 9.94% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 68.30% vs 7.58% in Dec 2024

Quarterly - Interest
Interest 3.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -64.58% vs -3.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -75.54% vs 107.46% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.93%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024